Over the last 7 days, the Pharma industry has remained flat, although notably Lumosa Therapeutics gained 11%. As for the the longer term, the industry is up 5.7% over the past 12 months. Looking forward, earnings are forecast to grow by 38% annually.
Has the Taiwanese Pharma Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Mon, 13 May 2024 | NT$614.8b | NT$102.3b | NT$9.4b | 27x | 65.3x | 6x |
Wed, 10 Apr 2024 | NT$706.9b | NT$101.5b | NT$9.2b | 26.8x | 76.8x | 7x |
Fri, 08 Mar 2024 | NT$652.9b | NT$101.9b | NT$8.6b | 24.6x | 76.1x | 6.4x |
Sun, 04 Feb 2024 | NT$596.7b | NT$101.9b | NT$7.8b | 23.7x | 76.6x | 5.9x |
Tue, 02 Jan 2024 | NT$580.1b | NT$101.9b | NT$7.8b | 23.9x | 74.4x | 5.7x |
Thu, 30 Nov 2023 | NT$582.1b | NT$101.6b | NT$7.7b | 24x | 76.1x | 5.7x |
Sat, 28 Oct 2023 | NT$557.5b | NT$101.7b | NT$9.7b | 21.7x | 57.5x | 5.5x |
Mon, 25 Sep 2023 | NT$544.5b | NT$101.7b | NT$9.6b | 22x | 56.6x | 5.4x |
Wed, 23 Aug 2023 | NT$543.1b | NT$101.7b | NT$9.6b | 21.6x | 56.3x | 5.3x |
Fri, 21 Jul 2023 | NT$595.5b | NT$98.7b | NT$10.1b | 17.1x | 59.2x | 6x |
Sun, 18 Jun 2023 | NT$583.7b | NT$98.6b | NT$10.1b | 16.9x | 58.1x | 5.9x |
Tue, 16 May 2023 | NT$552.3b | NT$92.2b | NT$8.6b | 19.3x | 64x | 6x |
Thu, 13 Apr 2023 | NT$582.3b | NT$91.2b | NT$8.5b | 21x | 68.4x | 6.4x |
Sat, 11 Mar 2023 | NT$543.4b | NT$85.1b | NT$6.8b | 21.2x | 79.4x | 6.4x |
Mon, 06 Feb 2023 | NT$507.8b | NT$84.6b | NT$7.9b | 21x | 64.4x | 6x |
Wed, 04 Jan 2023 | NT$499.7b | NT$84.6b | NT$7.9b | 21.1x | 63.4x | 5.9x |
Fri, 02 Dec 2022 | NT$488.3b | NT$84.6b | NT$7.9b | 16.3x | 61.9x | 5.8x |
Sun, 30 Oct 2022 | NT$389.9b | NT$79.1b | NT$4.3b | 17x | 89.6x | 4.9x |
Tue, 27 Sep 2022 | NT$430.2b | NT$78.9b | NT$4.3b | 17.5x | 99.4x | 5.4x |
Thu, 25 Aug 2022 | NT$455.7b | NT$78.9b | NT$4.3b | 18.5x | 105.2x | 5.8x |
Sat, 23 Jul 2022 | NT$385.5b | NT$76.7b | NT$4.4b | 21.3x | 86.7x | 5x |
Mon, 20 Jun 2022 | NT$396.2b | NT$76.8b | NT$4.4b | 21.5x | 90.7x | 5.2x |
Wed, 18 May 2022 | NT$367.5b | NT$76.7b | NT$4.3b | 20.3x | 85.9x | 4.8x |
Fri, 15 Apr 2022 | NT$408.5b | NT$76.5b | NT$6.5b | 21.6x | 62.5x | 5.3x |
Sun, 13 Mar 2022 | NT$380.8b | NT$76.7b | NT$8.5b | 20.5x | 44.6x | 5x |
Tue, 08 Feb 2022 | NT$385.8b | NT$76.7b | NT$8.5b | 18.9x | 45.6x | 5x |
Thu, 06 Jan 2022 | NT$384.5b | NT$76.7b | NT$8.5b | 18.4x | 45.4x | 5x |
Sat, 04 Dec 2021 | NT$387.4b | NT$76.7b | NT$8.5b | 17.7x | 45.8x | 5x |
Mon, 01 Nov 2021 | NT$377.1b | NT$76.0b | NT$10.4b | 17.6x | 36.1x | 5x |
Wed, 29 Sep 2021 | NT$357.7b | NT$76.0b | NT$10.7b | 19.5x | 33.3x | 4.7x |
Fri, 27 Aug 2021 | NT$352.2b | NT$76.0b | NT$10.7b | 20.1x | 32.8x | 4.6x |
Sat, 03 Jul 2021 | NT$369.1b | NT$76.0b | NT$10.7b | 19.1x | 34.4x | 4.9x |
28.3x
How does Taiwanese Pharma compare with similar industries?
TW Market | 1.59% | |
Healthcare | -0.31% | |
Pharma | -0.78% | |
Pharma | -0.78% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
6535 Lumosa Therapeutics | NT$190.00 | 10.8% +NT$3.1b | 313.0% | PS550.7x | |
6620 Handa Pharmaceuticals | NT$140.50 | 16.1% +NT$2.8b | -15.4% | PE27.3x | |
4123 Center Laboratories | NT$46.10 | 5.9% +NT$1.7b | 3.3% | PS22.7x | |
1720 Standard Chemical & Pharmaceutical | NT$67.90 | 6.9% +NT$786.3m | 1.2% | PE13.8x | |
3705 YungShin Global Holding | NT$52.80 | 5.8% +NT$772.5m | 18.4% | PE15.2x |